Depressive symptoms and Depo-Provera®

Contraception

Volumn 57, Issue 4, 1998, Pages 237-240

  Westhoff, Carolyn ^a,b   Truman, Christine ^a   Kalmuss, Debra ^b   Cushman, Linda ^b   Davidson, Andrew ^b   Rulin, Marvin ^c   Heartwell, Stephen ^d  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Contraception; Depo Provera ; Depression

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; DEPRESSION; DISEASE ASSOCIATION; DRUG IMPLANT; FEMALE; HUMAN; MULTICENTER STUDY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SCORING SYSTEM; SUSTAINED RELEASE PREPARATION; SYMPTOMATOLOGY;

EID: 0031843723     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00024-9     Document Type: Article

References (11)

1. Weissman M.M., Bland R.C., Canino G.J., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 276:1996;293-299.
2. Abma J, Chandra A, Mosher W, Peterson L, Piccinino L. Fertility, Family Planning, and Women's Health: New Data from the 1995 National Survey of Family Growth. National Center for Health Statistics, Vital Health Stat 1997;23.
3. Schwallie P., Assenzo J. Contraceptive use efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril. 24:1973;331-339.
4. Fraser I., Dennerstein G. Depo-Provera use in an Australian metropolitan practice. Med J Australia. 160:1994;553-556.
5. Sangi-Haghpeykar H., Poindexter A., Bateman L., Ditmore J. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol. 88:1996;227-233.
6. Westhoff C., Wieland D., Tiezzi L. Depression in users of depo-medroxyprogesterone acetate. Contraception. 51:1995;351-354.
7. Cromer B.A., Smith R.D., Blair J.M., Dwyer J. Brown RT. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics. 94:1994;687-694.
8. Cushman L., Kalmuss D., Davidson A., Heartwell S., Rulin M. Beliefs about Depo-Provera among three groups of contraceptors. Adv Contracep. 12:1996;43-52.
9. Davidson A., Kalmuss D., Cushman L.F., Romero D., Heartwell S., Rulin M. Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women. Am J Public Health. 87:1997;1532-1534.
10. Veit C., Ware J. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 51:1983;730-742.
11. Westhoff C., Truman C., Kalmuss D., et al. Depressive symptoms and Norplant contraceptive implants. Contraception. 57:1998;241-245.